IFNL1
Basic information
Region (hg38): 19:39296407-39298673
Previous symbols: [ "IL29" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (36 variants)
- not_provided (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IFNL1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000172140.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 32 | 37 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 32 | 4 | 3 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IFNL1 | protein_coding | protein_coding | ENST00000333625 | 5 | 2349 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000285 | 0.577 | 125711 | 0 | 36 | 125747 | 0.000143 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.118 | 122 | 118 | 1.03 | 0.00000689 | 1261 |
Missense in Polyphen | 26 | 29.703 | 0.87534 | 349 | ||
Synonymous | -0.189 | 57 | 55.2 | 1.03 | 0.00000330 | 453 |
Loss of Function | 0.552 | 6 | 7.65 | 0.784 | 3.24e-7 | 88 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000538 | 0.000537 |
Ashkenazi Jewish | 0.0000998 | 0.0000992 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000882 | 0.0000879 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000492 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Cytokine with antiviral, antitumour and immunomodulatory activities. Plays a critical role in the antiviral host defense, predominantly in the epithelial tissues. Acts as a ligand for the heterodimeric class II cytokine receptor composed of IL10RB and IFNLR1, and receptor engagement leads to the activation of the JAK/STAT signaling pathway resulting in the expression of IFN- stimulated genes (ISG), which mediate the antiviral state. Has a restricted receptor distribution and therefore restricted targets: is primarily active in epithelial cells and this cell type- selective action is because of the epithelial cell-specific expression of its receptor IFNLR1. Exerts an immunomodulatory effect by up-regulating MHC class I antigen expression.;
- Pathway
- Jak-STAT signaling pathway - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);JAK-STAT-Core;Type III interferon signaling;Other interleukin signaling;Signaling by Interleukins;Cytokine Signaling in Immune system;Interleukin-20 family signaling;Immune System
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- 0.08
- rvis_percentile_EVS
- 60.09
Haploinsufficiency Scores
- pHI
- 0.0682
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.396
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ifnl3
- Phenotype
- hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- negative regulation of type 2 immune response;JAK-STAT cascade;negative regulation of cell population proliferation;regulation of signaling receptor activity;cytokine-mediated signaling pathway;negative regulation of interleukin-13 production;negative regulation of interleukin-5 production;positive regulation of interferon-gamma production;positive regulation of tyrosine phosphorylation of STAT protein;negative regulation of memory T cell differentiation;innate immune response;positive regulation of MHC class I biosynthetic process;negative regulation of T cell differentiation;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;positive regulation of JAK-STAT cascade;positive regulation of immune response;defense response to virus
- Cellular component
- extracellular region;extracellular space;interleukin-28 receptor complex
- Molecular function
- signaling receptor binding;cytokine activity;interleukin-28 receptor binding